• Aifa: 66 thousand reports on over 32 million vaccine doses

  • Coronavirus, Istat-Iss: "The risk of death is reduced by 95% at 7 weeks from the first vaccine dose"

  • Australia, woman dies of thrombosis: vaccinated with Astrazeneca

  • AstraZeneca, Cts evaluates new indication on use for under 50s

  • Hope: "The CTS will consider the indications of the ministry and Aifa on AstraZeneca"

  • Vaccines, sold out at the open day for 12-16 year olds in Rieti

  • Locatelli: AstraZeneca recommended over 60, watch out for signs of side effects

Share

June 10, 2021 The news had been circulating for a few hours but confirmation arrived only in the late afternoon. Camilla Canepa, the 18-year-old from Sestri Levante hospitalized on Sunday at San Martino in Genoa after a cavernous sinus thrombosis and operated on to remove the thrombus and reduce intracranial pressure, died.



She had been vaccinated with AstraZeneca on May 25 on the open day for the over 18. "Unfortunately, a few hours ago, Sestri Levante was hit by a mourning that we never wanted to live - says the mayor of Sestri Valentina Ghio -. The administration municipal and the whole city gather around the family of the girl who disappeared today. In this moment of pain I express all my affection and my closeness to Camilla's family ".





The CTS assesses limitations for Under50

Right now, the CTS is evaluating a new indication on use for the under 50s. The choice of open days organized by the Regions is also under discussion. In the next few hours, the Technical Scientific Committee (Cts) could express itself with a new pronouncement on the use in vaccination strategy, in particular for the under 50s, Speranza: "The Cts will consider the indications of the ministry and Aifa on AstraZeneca". A decision is expected shortly because after new cases of hospitalizations for thrombosis, including that of the 18-year-old from Liguria, the use of the Vaxzevria vaccine, AstraZeneca, makes us think again. The choice of open days open to young people is also under discussion. The Technical Scientific Committee (Cts) in the next few hours could express itself with a new pronouncement onuse in vaccination strategy, especially for those under 50.